Rees S, Coote J, Stables J, Goodson S, Harris S, Lee M G
Receptor Systems Unit, Glaxo Wellcome Research and Development, Stevenage, Herts, UK.
Biotechniques. 1996 Jan;20(1):102-4, 106, 108-10. doi: 10.2144/96201st05.
We have developed an improved vector for the stable expression of recombinant protein in mammalian cells. In this vector, designated pCIN, both the recombinant cDNA and the neomycin phosphotransferase selection marker are transcribed from a single promoter element. To facilitate translation of the second open reading frame, the encephalomyocarditis virus internal ribosome entry site has been inserted into the expression cassette immediately before the start codon of this sequence. We report the use of this vector to generate stable cell lines expressing the human 5-HT1Da serotonin receptor and show that following transfection and clonal selection, all ten cell lines characterized express similar and high levels of receptor (1.5-11.9 pmol receptor/mg protein). Use of pCIN should permit the rapid and efficient production of stable mammalian cell lines for the characterization of recombinant protein, as this vector appears to predispose all transfected cells to express such protein.
我们开发了一种用于在哺乳动物细胞中稳定表达重组蛋白的改进载体。在这个名为pCIN的载体中,重组cDNA和新霉素磷酸转移酶选择标记均从单个启动子元件转录。为便于第二个开放阅读框的翻译,脑心肌炎病毒内部核糖体进入位点已被插入到表达盒中该序列起始密码子之前紧邻的位置。我们报道了使用该载体生成表达人5-HT1Da血清素受体的稳定细胞系,并表明转染和克隆选择后,所鉴定的所有十个细胞系均表达相似且高水平的受体(1.5 - 11.9 pmol受体/毫克蛋白)。使用pCIN应该能够快速高效地产生用于重组蛋白表征的稳定哺乳动物细胞系,因为该载体似乎使所有转染细胞都易于表达此类蛋白。